Evidence map›Paper›PMID 20229041›Full record

ArticleIntensive care medicine2010

Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia.

Anne Sofie Andreasen, Theis Pedersen-Skovsgaard, Ronan M G Berg, Kira Dynnes Svendsen, Bo Feldt-Rasmussen, Bente K Pedersen, Kirsten Møller

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Regional differences in cell-mediated immunity in people with diabetic peripheral neuropathy.Diabetic medicine : a journal of the British Diabetic Association · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus.International journal of inflammation · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anne Sofie AndreasenCentre of Inflammation and Metabolism, Department of Infectious Diseases, University Hospital Rigshospitalet, Rigshospitalet-M 7641, Blegdamsvej 9, 2100, Copenhagen, Denmark. sofie_andreasen@msn.com
Theis Pedersen-Skovsgaard
Ronan M G Berg
Kira Dynnes Svendsen
Bo Feldt-Rasmussen
Bente K Pedersen
Kirsten Møller
Rigshospitalet · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeType 2 diabetes is associated with an increased risk of acquiring infectious diseases and developing sepsis. This may partly be due to immune dysfunction. We investigated the in vivo innate immune response of type 2 diabetic persons to an intravenous injection of E. coli lipopolysaccharide (LPS).

methodsAfter ethics approval, informed consent and a thorough physical examination, 19 type 2 diabetic patients and 23 healthy controls were included. LPS was given as an intravenous bolus injection of 0.3 ng/kg. Physiological variables, white blood cell count, and plasma concentrations of tumour necrosis factor (TNF), interleukin-6 (IL-6), interleukin-1 receptor antagonist (IL-1ra), and the adhesion molecules E-selectin, vascular adhesion molecule (VCAM)-1, and intracellular adhesion molecule (ICAM)-1 were measured hourly for 8 h.

resultsLPS injection induced a systemic inflammatory response with increases in neutrophils, temperature, heart rate and plasma concentrations of cytokines and adhesion molecules in healthy and type 2 diabetic volunteers. Type 2 diabetes was associated with less pronounced LPS-induced increases in TNF, IL-1ra, VCAM-1 and ICAM-1. There was a trend towards an attenuated upregulation of E-selectin in diabetics, even though the plasma concentration tended to be generally higher compared to healthy controls.

conclusionsPatients with type 2 diabetes exhibit an attenuated increase in plasma levels of TNF and IL-1ra, as well as an attenuated upregulation of VCAM-1 and ICAM-1 to LPS in vivo. This finding may provide a mechanistic explanation for the adverse outcome seen during infectious diseases in diabetic patients.

Indexed as

Adaptive ImmunityAdultBiomarkersCell Adhesion MoleculesCytokinesDiabetes Mellitus, Type 2EndotoxemiaEndotoxinsHumansInterleukin-1LipopolysaccharidesMaleMiddle AgedTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1BiomarkersCell Adhesion MoleculesCytokinesendotoxin, Escherichia coliEndotoxinsInterleukin-1LipopolysaccharidesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1

Identifiers

PMID20229041
OpenAlexW1995550856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.